A
ANTERIOS
Innovative biopharmaceutical solutions tackling the toughest health challenges with a focus on impactful treatments
About ANTERIOS
Anterios Inc. operates in the biopharmaceutical industry, focusing on developing innovative treatments for some of the most challenging health conditions. The company serves a diverse range of clients, including healthcare providers, hospitals, and patients in need of advanced medical solutions. Anterios Inc. operates in a highly regulated market, adhering to stringent legal and ethical standards to ensure the safety and efficacy of its products. The business model is centered around research and development (R&D), where significant investments are made to discover and develop new drugs. Revenue is generated through the sale of these pharmaceutical products, licensing agreements, and partnerships with other healthcare organizations. The company aims to make a remarkable impact on people's lives by not only treating diseases but also improving overall health outcomes. Keywords: biopharmaceutical, innovative treatments, healthcare providers, hospitals, patients, regulated market, R&D, drug discovery, licensing, health outcomes.
Source: Dealroom company dataAt a glance
- Status
- Acquired
- Founded
- 2006
- Headquarters
- New York City, United States
- Employees
- 3
- Open positions
- None listed
- Dealroom signal
- 25.7/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Supply Chain Management, Testing, Risk Management, Biotechnology, Surgery, Cardiology and cardiovascular, Non-Invasive medical devices and treatments, Spinout, Biotech and Pharma, medical testing
- Business model
- Manufacturing
- Client focus
- b2c
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITION✓Exit | Jan 2016 | $90M | $90M | Allergan | — |
| IPO✓Exit | Apr 2015 | $0 | — | Undisclosed | — |
Growth signals
Latest recorded traffic for ANTERIOS is 0 monthly website visits. ANTERIOS's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Other known investors3 additional known investors
Allergan
University of California, Los Angeles
Scientific Health Development Partners
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about ANTERIOS on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See ANTERIOS’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.